Reed’s Reports Third Quarter 2022 Results


NORWALK, Conn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NASDAQ: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three months ended September 30, 2022.

Q3 2022 Financial Highlights (vs. Q3 2021):

  • Net sales were $12.1 million compared to $13.4 million.
  • Gross profit was $2.4 million compared to $3.9 million, with gross margin of 20.1% compared to 28.9%.
  • Operating expenses were reduced to $4.9 million compared to $7.5 million.
  • Operating loss improved to $2.5 million compared to a loss of $3.7 million.
  • Modified EBITDA loss improved to $2.2 million compared to $3.1 million.

Management Commentary

“We continued to navigate a challenging market environment during the third quarter, especially relative to our record net sales reached in Q3 2021,” said Norman E. Snyder, CEO of Reed’s. “Net sales for the quarter were further affected by a delayed shipment of swing-lid bottles that pushed approximately $3.8 million of sales into the fourth quarter, which impacted gross margin as these products are margin accretive. As of today, we have shipped over $3.0 million of these swing-lid bottles and expect to ship the rest before quarter end. Regardless of the delay, we continued to execute on our cost saving initiatives, as reflected by a 35% reduction in operating expenses led by a 27% reduction in shipping and handling costs, resulting in improved modified EBITDA for the quarter. We expect to further reduce costs in the months ahead as we generate additional savings in transportation and product costs.

“Looking forward, we are reducing our net sales and gross margin guidance for the year as a result of lower sales velocities driven by price increases and product mix. However, we continue to expect improving modified EBITDA in 2022 and turning both modified EBITDA and cash flow positive next year as we realize the full benefit of our cost saving and supply chain initiatives.”

Third Quarter 2022 Financial Results

During the third quarter of 2022, net sales were $12.1 million compared to $13.4 million in the prior year. The decrease was primarily driven by a delayed shipment of swing-lid bottles, shifting $3.8 million of net sales from the third quarter to the fourth quarter and increased trade spend.

Gross profit for the third quarter of 2022 was $2.4 million compared to $3.9 million in the same period in 2021. Gross margin was 20.1% compared to 28.9% in the year-ago quarter. The decrease was driven by lower revenue as well as higher promotional spend and sales mix.

Delivery and handling costs were reduced by 27% to $2.2 million during the third quarter of 2022 compared to $3.1 million in the third quarter of 2021. The decrease was primarily driven by a continued reduction in freight rates and fuel costs, as well as improved efficiencies. Delivery and handling costs were 19% of net sales or $3.38 per case, compared to 23% of net sales or $3.89 per case during the same period last year.

Selling and marketing costs were reduced by 54% to $1.2 million during the third quarter of 2022 compared to $2.6 million in the year-ago quarter. As a percentage of net sales, selling and marketing costs were reduced to 10% compared to 20%.

General and administrative expenses were reduced by 21% to $1.4 million compared to $1.8 million in the third quarter of 2021. As a percentage of net sales, general and administrative costs were reduced to 12% compared to 13%.

Operating loss during the third quarter of 2022 improved to $2.5 million or $(0.03) per share, compared to $3.7 million or $(0.04) per share in the third quarter of 2021, reflecting our lowest operating loss since Q3 2020.

Modified EBITDA loss improved to $2.2 million in the third quarter of 2022 compared to a loss of $3.1 million in the third quarter of 2021. Q3 Modified EBITDA loss of $2.2 million was an improvement of 43% versus Q1 and a 50% sequential improvement from Q2.

Liquidity and Cash Flow

For the third quarter of 2022, the Company used approximately $177,000 of cash in operating activities compared to $5.0 million of cash used for the same period in 2021. The improvement is driven by strong cash collections and a reduction in inventory.

As of September 30, 2022, the Company had approximately $25,000 of cash and $21.7 million of total debt net of capitalized financing fees. The Company also had $3.5 million of additional borrowing capacity on its revolving line of credit. The lower cash balance is a function of timing. As of October 31, 2022, the Company had approximately $253,000 of cash.

FY 2022 Financial Guidance and Outlook

Reed’s expects 2022 net sales to range between approximately $56-59 million, reflecting growth of approximately 13-19% from 2021. The Company also expects gross margin in 2022 to be approximately 25% compared to 27.4% in 2021.

Management remains committed to executing on cost savings initiatives to further reduce production and shipping costs, including prioritizing direct shipments, reducing raw material costs of cans and bottles, revisiting third-party logistics agreements, and optimizing distribution centers. These cost saving initiatives are calculated to result in improved modified EBITDA in fiscal 2022, with the Company turning modified EBITDA and cash flow positive in 2023.

Conference Call

The Company will conduct a conference call today, November 10, 2022, at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2022.

Reed’s management will host the conference call, followed by a question-and-answer period.

Date: Thursday, November 10, 2022
Time: 5:00 p.m. Eastern time
Toll-free dial-in number: (800) 239-9838
International dial-in number: (646) 828-8193
Conference ID: 5915539
Webcast: Reed’s Q3 2022 Conference Call

Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the company’s investor relations team at (720) 330-2829.

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://investor.reedsinc.com.

About Reed's, Inc.

Reed’s is an innovative company and category leader that provides the world with high quality, premium and naturally bold™ better-for-you beverages. Established in 1989, Reed's is a leader in craft beverages under the Reed’s®, Virgil’s® and Flying Cauldron® brand names. The Company’s beverages are now sold in over 45,000 stores nationwide.

Reed’s is known as America's #1 name in natural, ginger-based beverages. Crafted using real ginger and premium ingredients, the Reed’s portfolio includes ginger beers, ginger ales, ready-to-drink ginger mules, hard ginger ale, ginger shots, and ginger candies. The brand has recently successfully expanded into the zero-sugar segment with its proprietary, natural sweetener system.

Virgil's® is an award-winning line of craft sodas, made with the finest natural ingredients and without GMOs or artificial preservatives. The brand offers an array of great tasting, bold flavored sodas including Root Beer, Vanilla Cream, Black Cherry, Orange Cream, and more. These flavors are also available in nine zero sugar varieties which are naturally sweetened and certified ketogenic.

Flying Cauldron® is a non-alcoholic butterscotch beer prized for its creamy vanilla and butterscotch flavors. Sought after by beverage aficionados, Flying Cauldron is made with natural ingredients and no artificial flavors, sweeteners, preservatives, gluten, caffeine, or GMOs. 

For more information, visit drinkreeds.comvirgils.com and flyingcauldron.com.

Forward-Looking Statements

Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are typically identified by terms such as "estimate," "expect,” “forecast,” "guidance," "intend," “calculated,” "likely," "financial outlook," "plan, "potential," "predict," "probable," "project," "seek," "should," "will," and similar expressions. These forward-looking statements are based on current expectations and include our, management’s expectations and guidance for fiscal year 2022 under the heading “FY 2022 Financial Guidance and Outlook”. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties, and assumptions, many of which involve factors or circumstances that are beyond our control. Reed‘s 2022 guidance reflects year-to-date and expected future business trends and includes impacts of COVID-19 on the supply chain and logistics as of the date hereof. New supply chain challenges that may develop and further potential inflation cannot be reasonably estimated and are not factored into current fiscal 2022 guidance. These risks could materially impact our ability to access raw materials, production, transportation and/or other logistics needs.

Financial guidance should not be viewed as a substitute for full financial statements prepared in accordance with GAAP.

If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, Reed’s actual results could differ materially from the results expressed or implied by the forward-looking statements we make, including our ability to achieve our targets for the fiscal year ending December 31, 2022. The risks and uncertainties referred to above include, but are not limited to: risks associated with current economic uncertainties tied to the COVID-19 pandemic, including but not limited to its effect on customer demand for the our products and services and the impact of potential delays in supply of product inputs and customer payments; risks associated with new product releases; the impacts of further inflation; risks that customer demand may fluctuate or decrease; risks that we are unable to collect unbilled contractual commitments, particularly in the current economic environment; our ability to compete successfully and manage growth; our significant debt obligations; our ability to develop and expand strategic and third party distribution channels; our dependence on third party suppliers, brewers and distributors risks related to our international operations; our ability to continue to innovate; our strategy of making investments in sales to drive growth; increasing costs of fuel and freight, protection of intellectual property; competition; general political or destabilizing events, including the war in Ukraine, conflict or acts of terrorism; the effect of evolving domestic and foreign government regulations, including those addressing data privacy and cross-border data transfers; and other risks detailed from time to time in Reed’s public filings, including Reed’s annual report on Form 10-K filed on April 15, 2022 and subsequent reports filed with the Securities and Exchange Commission, including Reed’s Quarterly Report on Form 10-Q expected to be filed on or about November 14, 2022, which are available on the Securities and Exchange Commission’s web site at www.sec.gov. These forward-looking statements are based on current expectations and speak only as of the date hereof. Reed’s assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Investor Relations Contact

Sean Mansouri, CFA
Elevate IR
ir@reedsinc.com
(720) 330-2829

REED’S, INC. 
CONDENSED STATEMENTS OF OPERATIONS 
For the Three and Nine Months Ended September 30, 2022 and 2021 
(Unaudited) 
(Amounts in thousands, except share and per share amounts) 
                
               
 Three Months Ended  Nine Months Ended 
September 30,September 30, 
 2022  2021  2022  2021 
Net Sales$12,094  $13,402  $38,001  $36,818 
Cost of goods sold 9,659   9,530   29,335   25,824 
Gross profit 2,435   3,872   8,666   10,994 
                
Operating expenses:               
Delivery and handling expense 2,249   3,093   8,893   8,888 
Selling and marketing expense 1,220   2,644   5,623   7,493 
General and administrative expense 1,420   1,788   5,319   6,227 
Total operating expenses 4,889   7,525   19,835   22,608 
                
Loss from operations (2,454)  (3,653)  (11,169)  (11,614)
                
Interest expense (777)  (234)  (2,119)  (692)
Gain on extinguishment of PPP note payable -   -   -   770 
                
Net loss (3,231)  (3,887)  (13,288)  (11,536)
                
Dividends on Series A Convertible Preferred Stock -   -   (5)  (5)
                
Net Loss Attributable to Common Stockholders$(3,231) $(3,887) $(13,293) $(11,541)
                
Loss per share – basic and diluted$(0.03) $(0.04) $(0.13) $(0.13)
                
Weighted average number of shares outstanding – basic and diluted 112,717,818   93,644,935   101,525,154   90,400,832 


REED’S, INC. 
CONDENSED BALANCE SHEETS 
(Amounts in thousands, except share amounts) 
        
 September 30,  December 31, 
20222021 
 (Unaudited)    
ASSETS       
Current assets:       
Cash$25  $49 
Accounts receivable, net of allowance of $63 and $215, respectively 6,008   5,183 
Inventory 19,916   17,049 
Receivable from related party 1,502   933 
Prepaid expenses and other current assets 1,394   1,491 
Total current assets 28,845   24,705 
        
Property and equipment, net of accumulated depreciation of $727 and $561, respectively 826   992 
Intangible assets 626   624 
Total assets$30,297  $26,321 
        
LIABILITIES AND STOCKHOLDERS’ EQUITY       
Current liabilities:       
Accounts payable$9,575  $10,434 
Accrued expenses 228   286 
Revolving line of credit, net of capitalized financing costs of $403 and $0, respectively 9,103   10,229 
Payable to related party 1,811   614 
Current portion of convertible notes payable, net of debt discount of $492 and $0, respectively 4,414   - 
Current portion of lease liabilities 180   161 
Total current liabilities 25,311   21,724 
Convertible note payable, net of debt discount of $666 and $0, respectively, less current portion 8,165     
Lease liabilities, less current portion 257   394 
Total liabilities 33,733   22,118 
        
Stockholders’ equity (deficit):       
Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding 94   94 
Common stock, $.0001 par value, 180,000,000 shares authorized; 112,752,750 and 93,733,975 shares issued and outstanding, respectively 11   9 
Additional paid in capital 112,889   107,237 
Accumulated deficit (116,430)  (103,137)
Total stockholders’ equity (deficit) (3,436)  4,203 
Total liabilities and stockholders’ equity (deficit)$30,297  $26,321 


REED’S, INC.
CONDENSED STATEMENTS OF CASH FLOWS
For the Nine Months Ended September 30, 2022 and 2021
(Unaudited)
(Amounts in thousands)
        
 September 30,  September 30, 
20222021
Cash flows from operating activities:       
Net loss$(13,288) $(11,536)
Adjustments to reconcile net loss to net cash used in operating activities:       
Depreciation 79   106 
Gain on termination of leases -   (2)
Gain on extinguishment of PPP note payable -   (770)
Amortization of debt discount 307   162 
Amortization of prepaid financing costs 431   147 
Fair value of vested options 448   1,264 
Fair value of vested restricted shares granted to officers 137   234 
Common shares issued as financing costs 37   - 
Change in allowance for doubtful accounts (152)  (95)
Inventory write-downs 35   (64)
Accrued interest on convertible note 386   - 
Changes in operating assets and liabilities:       
Accounts receivable (673)  (2,132)
Inventory (2,901)  (4,332)
Prepaid expenses and other assets (399)  (491)
Decrease in right of use assets 86   74 
Accounts payable (860)  2,126 
Accrued expenses (62)  82 
Lease liability (118)  (78)
Net cash used in operating activities (16,507)  (15,305)
Cash flows from investing activities:       
Trademark costs (2)  (6)
Purchase of property and equipment -   (95)
Net cash used in investing activities (2)  (101)
Cash flows from financing activities:       
Proceeds from line of credit 40,576   49,940 
Payments on line of credit (41,299)  (41,685)
Payment of debt issuance costs (483)  - 
Proceeds from sale of common stock 5,034   7,327 
Proceeds from convertible note payable, net of expenses 12,430   - 
Repayment of convertible notes payable (400)    
Amounts from related party, net 629   155 
Payments on capital lease obligation -   (2)
Proceeds from exercise of options -   32 
Repurchase of common stock (2)  (15)
Net cash provided by financing activities 16,485   15,752 
        
Net increase (decrease) in cash (24)  346 
Cash at beginning of period 49   595 
Cash at end of period$25  $941 
        
Supplemental disclosures of cash flow information:       
Cash paid for interest$1,051  $258 
Non -cash investing and financing activities       
Dividends on Series A Convertible Preferred Stock$5  $5 

Modified EBITDA

In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus, interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.

Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended September 30, 2022 and 2021 (unaudited; in thousands):

 Three Months Ended 
September 30,
 2022  2021 
Net loss$(3,231) $(3,887)
        
Modified EBITDA adjustments:       
Depreciation and amortization 58   62 
Interest expense 777   234 
Stock option and other noncash compensation 214   501 
Total EBITDA adjustments$1,050  $797 
        
Modified EBITDA$(2,182) $(3,090)

We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:

  • Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
  • Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
  • Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
  • Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.